No black box warning on record for Flumazenil

As of the latest FDA labeling reviewed, Flumazenil (FLUMAZENIL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Flumazenil medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Risk of Seizures The reversal of benzodiazepine effects may be associated with the onset of seizures in certain high-risk populations. Possible risk factors for seizures include: concurrent major sedative-hypnotic drug withdrawal, recent therapy with repeated doses of parenteral benzodiazepines, myoclonic jerking or seizure activity prior to flumazenil administration in overdose cases, or

No black box warning on record for Flumazenil

Other warnings & precautions

WARNINGS Risk of Seizures The reversal of benzodiazepine effects may be associated with the onset of seizures in certain high-risk populations. Possible risk factors for seizures include: concurrent major sedative-hypnotic drug withdrawal, recent therapy with repeated doses of parenteral benzodiazepines, myoclonic jerking or seizure activity prior to flumazenil administration in overdose cases, or

Flumazenil Black Box Warning

No black box warning on record for Flumazenil

Other warnings & precautions

Flumazenil Black Box Warning

No black box warning on record for Flumazenil

Other warnings & precautions